Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1989-08-29
1991-06-25
Dentz, Bernard
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514315, 514328, 546116, 546219, 546220, 546242, C07D21142, C07D491056
Patent
active
050267132
ABSTRACT:
Novel compounds represented by the formula: ##STR1## wherein R represents hydrogen, optionally substituted alkyl radicals having from 1 to about 10 carbon atoms, optionally substituted alkenyl radicals having from 1 to about 10 carbon atoms, optionally substituted aryl, alkaryl and aralkyl radicals having from about 6 to about 16 carbon atoms and optionally substituted acyl and acyloxy radicals having from about 1 to about 10 carbon atoms, manifest glycosidase inhibition activity.
REFERENCES:
patent: 4348402 (1982-09-01), Kinast et al.
DeCrescenzo Gary A.
Getman Daniel P.
Bolding James C.
Dentz Bernard
Monsanto Company
Smith Charles E.
Williams, Jr. James W.
LandOfFree
1,3-dideoxy-3-fluoronojirimycin which inhibits glycosidase activ does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 1,3-dideoxy-3-fluoronojirimycin which inhibits glycosidase activ, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 1,3-dideoxy-3-fluoronojirimycin which inhibits glycosidase activ will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1040102